- What is eribulin mesylate, Halaven, and how does it work (mechanism of action)?
- What brand names are available for eribulin mesylate, Halaven?
- Is eribulin mesylate, Halaven available as a generic drug?
- Do I need a prescription for eribulin mesylate, Halaven?
- What are the side effects of eribulin mesylate, Halaven?
- What is the dosage for eribulin mesylate, Halaven?
- Which drugs or supplements interact with eribulin mesylate, Halaven?
- Is eribulin mesylate, Halaven safe to take if I'm pregnant or breastfeeding?
- What else should I know about eribulin mesylate, Halaven?
What is eribulin mesylate, Halaven, and how does it work (mechanism of action)?
Microtubules are dynamic intracellular structures that are responsible for various kinds of movements including cell division, organization of intracellular structure, and intracellular transport. Eribulin inhibits the growth phase of microtubules, consequently interfering with cell growth and function and eventually causing cancer cell death. Eribulin was developed from a chemical first isolated from the rare marine sponge, Halichondria okadai.
Eribulin can help some patients with metastatic breast cancer live longer. In one trial, women treated with eribulin lived about 2.5 months longer than women who received other treatments. Eribulin was approved by the FDA in 2010.
What are the side effects of eribulin mesylate, Halaven?
The most common side effects of eribulin are:
- low white blood cells,
- low red blood cells,
- hair loss,
- nausea, and
- numbness, tingling, or burning in the hands and feet (peripheral neuropathy).
The most common serious side effect is decreased white blood cell counts or neutropenia. White blood cells are necessary to fight infections; therefore, significantly low levels of white blood cells may increase the risk for serious infections that can lead to hospitalization or death.
Peripheral neuropathy (damage to the nerves of the extremities) is the most common side effect that causes patients to stop taking eribulin. Severe peripheral neuropathy occurred in 8% of patients treated with eribulin. Furthermore, 5% of patients experienced neuropathy lasting more than 1 year, while 22% of patients developed new or worsening neuropathy that did not get better after an average of 269 days.
Eribulin also can cause abnormalities in the electrocardiogram such as QT prolongation and changes in the heartbeat rhythm that can potentially cause death.
Eribulin can damage the kidney or liver. Risk for injury is higher in patients who have pre-existing kidney or liver disease. To avoid serious injury, such patients should be treated with a lower dose of eribulin.
What is the dosage for eribulin mesylate, Halaven?
The recommended dose of eribulin is 1.4 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21 day cycle of chemotherapy.
The recommended dose of eribulin in patients with mild liver disease (Child-Pugh A) is 1.1 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21 day cycle.
The recommended dose of eribulin in patients with moderate liver disease (Child-Pugh B) is 0.7 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
The recommended dose of eribulin in patients with moderate or severe kidney disease (creatinine clearance 15-49 ml/min) is 1.1 mg/m2 administered into the vein (intravenously) over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
The dose of eribulin may need to be decreased or treatment may need to be temporarily or permanently interrupted if patients experience a significant drop in their blood cell counts (red blood cells, white blood cells, and/or platelets) or severe peripheral neuropathy.
Eribulin may be administered undiluted or diluted in 100 ml of 0.9% normal saline (salt water). Eribulin should not be mixed with or administered in the same line as solutions containing dextrose (sugar).
Which drugs or supplements interact with eribulin mesylate, Halaven?
Eribulin may cause abnormal heart beats. Combining eribulin with other drugs with a similar effect on the heart increases the risk of developing abnormal heart beats.
Is eribulin mesylate, Halaven safe to take if I'm pregnant or breastfeeding?
Eribulin has not been adequately evaluated in pregnant women. However, based on the mechanism in which eribulin works in the body, it is expected to cause harm to the unborn baby and therefore, should not be used during pregnancy. In animal studies eribulin caused birth defects in rats. Eribulin is classified as FDA pregnancy risk category D.
It is not known if eribulin is excreted in breast milk. As many drugs enter human milk and can potentially cause harm to the nursing infant, eribulin is not recommended in nursing mothers.
What else should I know about eribulin mesylate, Halaven?
What preparations of eribulin mesylate, Halaven are available?
Solution for intravenous (IV) injection: 1 mg/2 ml. Eribulin is available in single use vials.
How should I keep eribulin mesylate, Halaven stored?
Eribulin should be stored at room temperature, between 15 C to 30 C (59 F to 86 F). Vials should be stored in their original cartons.
After drawing into the syringe, undiluted eribulin can be stored for up to 4 hours at room temperature or for up to 24 hours in the refrigerator (4 C or 40 F).
Quick GuideBreast Cancer Diagnosis and Treatment
Eribulin mesylate (Halaven) is a chemotherapy agent used to treat metastatic breast cancer by interfering with the growth of crucial intracelluar structures. Side effects, drug interactions, and use during pregnancy should be reviewed prior to taking any medication.
Multimedia: Slideshows, Images & Quizzes
Breast Cancer Quiz: Symptoms & Signs
This Breast Cancer Quiz features signs, symptoms, facts, causes, common forms, terms, risk factors, statistics, and more. ...
Picture of Breast Anatomy
The breast refers to the front of the chest or, more specifically, to the mammary gland. See a picture of Breast Anatomy and...
Breast Cancer Diagnosis and Treatment
Learn about breast cancer causes, symptoms, tests, recovery, and prevention. Discover the types of treatments such as surgery and...
Related Disease Conditions
Second Source article from Government...
Breast Cancer in Men
Second Source WebMD Medical Reference...
Breast cancer is an invasive tumor that develops in the mammary gland. Breast cancer is detected via mammograms, breast...
Breast Cancer Prevention
Lifestyle changes, a healthy antioxidant-rich diet, exercise, and weight reduction can help reduce a woman's risk of developing...
Breast Lumps (In Women)
Breast lumps in women can have a variety of causes such as breast inflammation, infection, injuries, cancer, and non-cancerous...
Breast Cancer and Coping With Stress
Being diagnosed with breast cancer is stressful. Learning relaxation techniques, exercising, eating well, getting adequate sleep,...
Breast Cancer and Lymphedema
Lymphedema is a common chronic, debilitating condition in which excess fluid called lymph collects in tissues and causes swelling...
Breast Cancer During Pregnancy
Breast cancer occurs in about 1 in every 1,000 pregnant women. Treatment of breast cancer during pregnancy involves surgery, but...
Breast Cancer Recurrence
Breast cancer most often recurs within the first three to five years after the initial treatment. Changes in the look, feel, or...
Breast Cancer Clinical Trials
Breast cancer clinical trials are research programs designed to evaluate new medical treatments, drugs, or devices for the...
Breast Cancer in Young Women
About 5% of cases of breast cancer occur in women under the age of 40 years old. Some risk factors for breast cancer in young...
Inflammatory Breast Cancer
Inflammatory breast cancer is an accelerated form of breast cancer that is not usually detected by mammogram or ultrasound....
Estimating Breast Cancer Risk: Questions and Answers
As breast cancer is the most diagnosed non-skin cancer in American women, it is important to know your breast cancer risk. Risk...
A liposarcoma is a cancerous tumor that develops in the soft deep tissue fat cells. Symptoms and signs include a growing lump...
Treatment & Diagnosis
- Breast Cancer FAQs
- Advanced Breast Cancer in Young Women Increasing
- Breast Cancer Risk - Reduced With Exercise
- Herceptin Metastatic Breast Cancer Treatment
- Hormone Therapy in Survivors of Breast Cancer
- Breast Cancer: Types of Breast Cancer
- Exercise Improves Breast Cancer Survival
- Stress and Aggressive Breast Cancer: Cause or Effect?
- Breast Cancer Detection
- Breast Cancer Treatment
- Breast Cancer and Kylie Minogue - Audio Podcast
Prevention & Wellness
- 2 Genetic Variants for Breast Cancer Identified
- 'Angelina Jolie Effect' Prompted More Testing for Breast Cancer Genes: Study
- 'Freezing' Technique May Work for Some Women With Early Breast Cancer
- 2 Pre-Surgery Drug Treatments Show Promise Against Aggressive Breast Cancer
- 1 in 4 Breast Cancer Diagnoses May Spur PTSD
- 'Chemo Brain' After Breast Cancer Backed by Study
- 'Freezing' Secondary Breast Cancer Tumors Shows Promise
- 'Chemo Brain' May Linger 20 Years After Breast Cancer Treatment
- 'Fat Transfer' Gets Early Safety OK in Breast Reconstruction
- 'Lab on a Chip' Might Speed Breast Cancer Monitoring
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
FDA Prescribing Information